Parvovirus
Researchers' work from National Institute for Biological Standards and Control focuses on parvovirus
Published in Medical Letter on the CDC and FDA, January 13th, 2008
Current study results from the report, 'Human parvovirus PARV4 in clotting factor VIII concentrates,' have been published. According to a study from Potters Bar, the United Kingdom, "Parvoviruses are small non-enveloped DNA viruses, relatively resistant to virus inactivation procedures. The recently identified human parvovirus PARV4, including a related genotype 2 virus (also termed PARV5), has been found to be a contaminant of pooled plasma used in the manufacture of plasma-derived products."
"This report describes an investigation to determine whether PARV4 is present in clotting factor concentrates. Factor VIII concentrates manufactured in the past 30-35 years were...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
More Articles from Medical Letter on the CDC and FDA
- Drug Resistance
Pfizer Receives Approvable Letter from FDA for Dalbavancin - Peripheral T-Cell Lymphoma
Status: - Cancer Gene Therapy
Data on cancer gene therapy discussed by K. Grønbaek and colleagues - Nanospheres
Researchers from Gwangju Institute of Science and Technology detail new studies and findings in the area of nanospheres - Anthrax
Studies from H.F. Duan and co-researchers update current data on anthrax - Chemical Warfare
Data from University of Oxford provide new insights into chemical warfare - More from this issue of Medical Letter on the CDC and FDA
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
